Nykredit A S Takes $15.51 Million Position in Corteva, Inc. $CTVA

Nykredit A S bought a new position in shares of Corteva, Inc. (NYSE:CTVA) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 183,138 shares of the company’s stock, valued at approximately $15,510,000.

Several other hedge funds have also bought and sold shares of the business. EFG International AG acquired a new position in shares of Corteva during the second quarter valued at about $25,000. Compass Financial Management LLC acquired a new stake in shares of Corteva in the 2nd quarter worth about $25,000. JPL Wealth Management LLC acquired a new stake in shares of Corteva in the 3rd quarter worth about $25,000. Garton & Associates Financial Advisors LLC bought a new position in Corteva in the 4th quarter valued at about $27,000. Finally, Bank of Jackson Hole Trust acquired a new position in Corteva during the 4th quarter valued at about $28,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

CTVA stock opened at $87.78 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The firm has a market cap of $58.57 billion, a PE ratio of 58.13, a P/E/G ratio of 2.72 and a beta of 0.57. The business has a 50 day moving average of $83.42 and a 200-day moving average of $81.00. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $90.97.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. During the same period last year, the company posted $2.20 earnings per share. Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, sell-side analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s payout ratio is 47.68%.

Analysts Set New Price Targets

Several brokerages have recently commented on CTVA. JPMorgan Chase & Co. increased their price objective on Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research note on Monday, August 3rd. UBS Group cut their target price on Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 18th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Morgan Stanley increased their price target on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Finally, Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average price target of $91.50.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.